The Leningrad-3 mumps attenuated strain was developed in the Soviet Union in guinea-pig kidney cell culture, with further passages in Japanese quail embryo cultures. Vaccines based on the Leningrad-3 strain have been used since 1974 in the former Soviet Union and other countries. Approximately 8–11 million doses of Leningrad-3 mumps vaccine are produced annually